WebNov 2, 2024 · The New Board Members Will Bring Industry Experience to Contribute to Company Growth. WOODINVILLE, Wash., Nov. 2, 2024 /PRNewswire/ -- Anavasi Diagnostics ('Anavasi'), an NIH/RADx medical technology company focused on the development of novel molecular diagnostic testing, recently announced the election of three new outside … WebInvesting.com - Liquidia Technologies (NASDAQ: LQDA) reported first quarter EPS of $-0.080, $0.07 better than the analyst estimate of $-0.155. Revenue for the quarter came in at... Liquidia...
LQDA Insider Trading Activity Liquidia Insider Buys and Sells
WebAug 12, 2024 · Liquidia Corp (LQDA) Price: $5.90 Shares Outstanding: 64M Market Cap: $320M Cash: $70M (Only used 70% of cash balance – not profitable) LT Debt: $24M EV: $274M The complicated nature of this special situation resulted in this analysis being longer than my normal posts. Therefore I wanted to include a quick summary of the analysis. WebReddit Liquidia (LQDA) Company Profile Liquidia Corporation is a biopharmaceutical company focused on the development and commercialization of products in pulmonary hypertension and other applications of its PRINT technology. The Company operates through two subsidiaries, Liquidia Technologies, Inc. and Liquidia PAH, LLC. have a relationship意思
ANAVASI DIAGNOSTICS ANNOUNCES NEWLY ELECTED OUTSIDE …
WebLiquidia Corporation (NASDAQ:LQDA) Q4 2024 Earnings Call Transcript Liquidia Corporation (NASDAQ:LQDA) Q4 2024 Earnings Call Transcript March 16, 2024 Operator: Good … WebI have been researching LQDA for a while and have been planning on doing a long write-up for WSB. News is out, however, and I think the stock is going to $20. I have included some WebLiquidia Corp - Company Profile and News - Bloomberg Markets Bloomberg Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg … boring antonym